Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
R. Dummer, S. Goldinger, C. Turtschi, N. Eggmann +6 more
2014European Journal of Cancer290 citations
Semantic Scholar

